Advanced pancreatic cancer: The standard of care and new opportunities | Zendy

Amrallah A. Mohammad | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Advanced pancreatic cancer: The standard of care and new opportunities

Author(s) -

Amrallah A. Mohammad

Publication year - 2018

Publication title -

oncology reviews

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.637

H-Index - 21

eISSN - 1970-5565

pISSN - 1970-5557

DOI - 10.4081/oncol.2018.370

Subject(s) - medicine , pancreatic cancer , cancer , standard of care , presentation (obstetrics) , intensive care medicine , mortality rate , oncology , surgery

Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged. In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research